Regulation of lipogenesis in human hepatocytes by androgens, glucocorticoids and 5α-reductase. * N Nikolaou1, M Nasiri2, LL Gathercole1, S Parajes2, N.

Slides:



Advertisements
Similar presentations
Substrates for lipid synthesis Phosphatidate is a precursor of storage and membrane lipids Formed by the addition of two fatty acids to glycerol 3-phosphate.
Advertisements

BIOLOGICAL MODELS International Science Forum on Computational Toxicology May 21–23, 2007 Research Triangle Park, North Carolina Hugh A. Barton 1, Laura.
Glutamate transporter SLC1A1 is dysregulated in SN38- and Oxaliplatin-resistant colorectal cancer cells Elena Pedraz-Cuesta 1, Sandra Christensen 1, Anders.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Discovery of a New Role of Human Resistin in Hepatocyte.
Endocrine Block Glucose Homeostasis Dr. Usman Ghani.
Volume 14, Issue 2, Pages (August 2011)
P356 Visceral fat drives 5alpha-reductase activity independent of body mass index in women with polycystic ovarian syndrome Punith Kempegowda1, Michael.
Figure 1. GLP-1 induces miR-132 and miR-212 expressions in pancreatic β-cells in vitro. A, miRNA expression profiling of GLP-1-treated INS-1 832/3 cells.
The Endocrine Pancreas
Fig. 1 UGT2B15 mRNA levels are stimulated by E2 in a time- and dose-dependent manner in MCF-7 breast cancer cells. A, Time course for E2 treatment. Cells.
Samir Parekh, Frank A. Anania  Gastroenterology 
1. ABSTRACT MiRNAs, a family of small non-coding RNAs, have emerged as novel post-transcriptional regulators of numerous cellular responses. Although the.
Glucose Homeostasis By Dr. Sumbul Fatma.
Discussion and Conclusion
Relationship with Bile acids and Microbiota
The Glucocorticoid Receptor Controls Hepatic Dyslipidemia through Hes1
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia by Josephine Aimiuwu, Hongyan.
Role of Lipotoxicity and Gut-Liver Axis in NASH Pathogenesis
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
Xiang Li, Feng Xu, Ekapun Karoopongse, A
Cell Signaling.
Volume 15, Issue 5, Pages (May 2012)
Volume 66, Issue 4, Pages (April 2017)
Nat. Rev. Endocrinol. doi: /nrendo
X. Zhang, I. Prasadam, W. Fang, R. Crawford, Y. Xiao 
Samir Parekh, Frank A. Anania  Gastroenterology 
therapy and to block androgen action
Volume 134, Issue 2, Pages (February 2008)
Michèle Algarté-Génin, Olivier Cussenot, Pierre Costa  European Urology 
High T Gives β Cells a Boost
Sugar, Sugar Not So Sweet for the Liver
Volume 7, Issue 3, Pages (March 2008)
Volume 18, Issue 13, Pages (March 2017)
NRG4: An Endocrine Link between Brown Adipose Tissue and Liver
Volume 134, Issue 4, Pages (April 2008)
ENDOCRINE SYSTEM.
Volume 126, Issue 3, Pages (March 2004)
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Volume 23, Issue 6, Pages (June 2016)
Volume 62, Issue 6, Pages (June 2015)
Volume 10, Issue 5, Pages (November 2009)
Volume 19, Issue 2, Pages (February 2014)
Volume 14, Issue 1, Pages (July 2011)
A Ceramide-Centric View of Insulin Resistance
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Volume 14, Issue 4, Pages (October 2011)
Volume 3, Issue 2, Pages (February 2006)
Volume 15, Issue 6, Pages (June 2012)
Volume 134, Issue 6, Pages (September 2008)
Volume 8, Issue 5, Pages (November 2008)
William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian 
Volume 14, Issue 2, Pages (August 2011)
Volume 15, Issue 2, Pages (April 2016)
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Knockdown of MPST weakens JNK phosphorylation, ameliorates hepatic oxidative stress and suppresses the release of MCP-1. Knockdown of MPST weakens JNK.
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Volume 16, Issue 4, Pages (October 2012)
Statins Molecular mechanisms of action SREBP feedback control
Phosphate and the parathyroid
The Salt-Inducible Kinases: Emerging Metabolic Regulators
The Modulation of Aromatase and Estrogen Receptor Alpha in Cultured Human Dermal Papilla Cells by Dexamethasone: A Novel Mechanism for Selective Action.
Glucagon – A hormone from pancreas Lecture NO: 2nd MBBS
Identification of divergent effects of FEN in fully differentiated adipocytes. Identification of divergent effects of FEN in fully differentiated adipocytes.
Sander Lefere, Frank Tacke  JHEP Reports 
Volume 9, Issue 4, Pages (April 2009)
The Endocrine Pancreas
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
Presentation transcript:

Regulation of lipogenesis in human hepatocytes by androgens, glucocorticoids and 5α-reductase. * N Nikolaou1, M Nasiri2, LL Gathercole1, S Parajes2, N Krone2, G Valsamakis3, G Mastorakos3, JW Tomlinson1 1University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism, United Kingdom 2University of Birmingham, Centre for Endocrinology, Diabetes and Metabolism, United Kingdom 3Endocrine Unit, Aretaieion Hospital, University of Athens, Medical School, Athens, Greece Background Non-alcoholic fatty liver disease [NAFLD] is rapidly becoming the commonest cause of liver cirrhosis and leading indication for liver transplant worldwide. It is tightly associated with obesity and type 2 diabetes, yet the precise mechanisms that drive its aetiology are not fully defined. Dysregulation of both glucocorticoid and androgen metabolism has been implicated in its pathogenesis. The availability of these hormones to bind and activate their receptors is regulated by 5α-reductase type 2 [5αR2] that inactivates glucocorticoids and converts testosterone [T] to dihydrotestosterone [DHT]. We have therefore explored the role of androgens and glucocorticoids and their metabolism by 5αR2 upon lipid homeostasis in human hepatocytes. Methods C3A human hepatoma cells and primary human hepatocytes were cultured and treated with Testosterone [T] (5nM, 50nM) or the more potent androgen, Dihydrotestosterone [DHT] (1nM, 10nM) for 24h. Lipid accumulation was measured by C14 acetate incorporation into triglyceride and gene expression by real-time PCR. As an additional model of androgen excess, cells were transfected with an androgen receptor (AR) construct (pcDNA3.1+AR) or vector alone as a control. In addition, C3A cells were treated with Cortisol and transfected with a 5α-reductase (SRD5A2) construct and lipid accumulation was measured as previously. Finally, pharmacological inhibitors of 5α-reductase isoforms were used in primary cultures of human hepatocytes. Between-group comparisons were made with T-Test and ANOVA. Results Despite androgen receptor (AR) expression being undetectable in C3A cells, FAS, ACC1, ACC2 and CPT1 mRNA expression was significantly increased after treatment with testosterone and DHT in a dose-dependent manner (figure 1) suggesting a receptor independent action. Endorsing these data, both testosterone and DHT increased de novo lipogenesis [DNL] as measured by C14-acetate incorporation into triglyceride (ctrl 100% vs. T (50nM, 24h) 124.9±6.2%, DHT (10nM, 24h) 128.1±4.7%), p<0.05) (figure 2). Following AR transfection, even in the absence of ligand, lipogenic gene expression increased (figure 3) as did de novo lipogenesis (figure 4) suggesting a ligand-independent action (ctrl 100% vs. AR 202.7±5.3%, p<0.05). Similar observations were made in primary human hepatocytes from female, but not male donors (figure 5). Glucocorticoids decreased DNL, an effect that was abrogated by overexpression of 5αR2 and augmented by pharmacological inhibition of 5αR2 activity (e.g. 88.3±5.3 vs. 76.9± 5.2%, cortisol vs. cortisol + finasteride, p=0.05) (figures 6,7,8). Impact of androgens on lipid metabolism in C3A human hepatoma cells. Impact of AR over expression on lipid metabolism. Gene expression. Lipogenesis. Gene expression. * * * * * Figure 4: De novo lipogenesis increased across transfection in C3A cells. Data shown as % change from control. Figure 3: mRNA expression in C3A human hepatoma cells increased across transfection with AR measured by real time PCR. Data shown as the mean of arbitrary units (AU). Impact of androgens on lipid metabolism in primary human hepatocytes. Impact of glucocorticoids on lipid metabolism in primary human hepatocytes. Figure 1: mRNA expression of FASN, ACC1, ACC2 and CPT1 in C3A human hepatoma cells increased across dose dependent treatment with testosterone and DHT. Data shown as the mean of arbitrary units (AU). * † Lipogenesis. * * Figure 2: De novo lipogenesis in C3A cells increased across treatment with testosterone and DHT measured by scintillation counting. Data shown as % change from control. Figure 6 Figure 7 ** * De novo lipogenesis decreased across treatment with cortisol (figure 6), but was restored by SRD5A2 overexpression (figure 7) and augmented by 5aR2 inhibitors (figure 8). Data shown as % change from control. Figure 5: De novo lipogenesis in primary human hepatocytes increased across treatment with testosterone but not with DHT measured by scintillation counting. Data shown as % change from control. Figure 8 Conclusion Increased mRNA expression of FAS, ACC1 and ACC2 as well decreased CPT1 mRNA expression contribute to the increase in de novo lipogenesis that is observed with testosterone and DHT treatment. Surprisingly, we also observed that AR overexpression alone, in the absence of ligand, also regulates hepatic lipid metabolism by increasing both the expression of key components of the lipogenic pathway (FAS, ACC1, ACC2) and functional lipid accumulation. We have shown that glucocorticoids decrease de novo lipogenesis in a dose-dependent manner and manipulation of 5αR2 activity can regulate lipogenesis in human hepatocytes in vitro. These data demonstrate that androgens and glucocorticoids are able to stimulate lipid accumulation in human hepatocytes and this may be crucial in understanding the association between PCOS and NAFLD.